Abstract
Ewing's sarcoma is the second most common bone malignancy in children or young adults and is caused by an oncogenic transcription factor by a chromosomal translocation between the EWSR1 gene and the ETS transcription factor family. However, the transcriptional mechanism of EWS-ETS fusion proteins is still unclear. To identify the transcriptional complexes of EWS-ETS fusion transcription factors, we applied a proximal labeling system called BioID in Ewing's sarcoma cells. We identified AHDC1 as a proximal protein of EWS-ETS fusion proteins. AHDC1 knockdown showed a reduced cell growth and transcriptional activity of EWS-FLI1. AHDC1 knockdown also reduced BRD4 and BRG1 protein levels, both known as interacting proteins of EWS-FLI1. Our results suggest that AHDC1 supports cell growth through EWS-FLI1.
MeSH terms
-
Cell Cycle Proteins / metabolism
-
Child
-
DNA
-
DNA-Binding Proteins / genetics
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Nuclear Proteins / genetics
-
Oncogene Proteins, Fusion / metabolism
-
Proto-Oncogene Protein c-fli-1 / genetics
-
Proto-Oncogene Protein c-fli-1 / metabolism
-
RNA-Binding Protein EWS / genetics
-
RNA-Binding Protein EWS / metabolism
-
Sarcoma, Ewing* / pathology
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
Substances
-
AHDC1 protein, human
-
BRD4 protein, human
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
EWS-FLI fusion protein
-
Nuclear Proteins
-
Oncogene Proteins, Fusion
-
Proto-Oncogene Protein c-fli-1
-
RNA-Binding Protein EWS
-
Transcription Factors
-
DNA
Grants and funding
This research was supported by Grant-in-Aid for Scientific Research (C) (Grant number: 18K07199) from the Japan Society for the Promotion of Science (to TK) and the Specific Research Grants (Grant number: 2019081196) from the Takeda Science Foundation (to MFS).